Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy
Public ClinicalTrials.gov record NCT05617820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Inserts 4 mcg (Teva Pharmaceuticals, Inc.) With IMVEXXY® (Estradiol Vaginal Inserts) (TherapeuticsMD, Inc.) in the Treatment of Dyspareunia in Women With Vulvar and Vaginal Atrophy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized, double-blind, placebo-controlled, parallel-designed, multiple-site, bioequivalence study with clinical endpoints.
Study identification
- NCT ID
- NCT05617820
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,050 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2022 (Actual)
- Primary completion
- Mar 15, 2024 (Actual)
- Completion
- Mar 15, 2024 (Actual)
- Last update posted
- Sep 30, 2026
2022 – 2024
United States locations
- U.S. sites
- 42
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 10112 | Birmingham | Alabama | 35218 | — |
| Site 10146 | Chandler | Arizona | 85224 | — |
| Site 10103 | Sacramento | California | 95821 | — |
| Site 10124 | Sacramento | California | 95821 | — |
| Site 10135 | San Diego | California | 92111 | — |
| Site 10136 | Milford | Connecticut | 06460 | — |
| Site 10130 | Edgewater | Florida | 32132 | — |
| Site 10123 | Hialeah | Florida | 33351 | — |
| Site 10139 | Lake Worth | Florida | 33461 | — |
| Site 10115 | Leesburg | Florida | 34748 | — |
| Site 10138 | Maitland | Florida | 32751 | — |
| Site 10107 | Miami Lakes | Florida | 33014 | — |
| Site 10144 | Miami Lakes | Florida | 33014 | — |
| Site 10101 | Miami Springs | Florida | 33166 | — |
| Site 10106 | New Port Richey | Florida | 34652 | — |
| Site 10143 | Oldsmar | Florida | 34677 | — |
| Site 10129 | Ormond Beach | Florida | 32174 | — |
| Site 10116 | Palm Harbor | Florida | 34684 | — |
| Site 10117 | Sarasota | Florida | 34239 | — |
| Site 10121 | Sunrise | Florida | 33351 | — |
| Site 10140 | Tampa | Florida | 33614 | — |
| Site 10119 | West Palm Beach | Florida | 33409 | — |
| Site 10113 | Norcross | Georgia | 30093 | — |
| Site 10104 | Wichita | Kansas | 67226 | — |
| Site 10128 | Marrero | Louisiana | 70072 | — |
| Site 10109 | Metairie | Louisiana | 70001 | — |
| Site 10122 | New Orleans | Louisiana | 70127 | — |
| Site 10105 | Saginaw | Michigan | 95821 | — |
| Site 10111 | Las Vegas | Nevada | 89128 | — |
| Site 10147 | North Las Vegas | Nevada | 89030 | — |
| Site 10126 | Lawrenceville | New Jersey | 08648 | — |
| Site 10137 | New Bern | North Carolina | 28562 | — |
| Site 10145 | New Bern | North Carolina | 28562 | — |
| Site 10134 | Philadelphia | Pennsylvania | 19114 | — |
| Site 10102 | Upper Saint Clair | Pennsylvania | 15241 | — |
| Site 10110 | North Charleston | South Carolina | 29405 | — |
| Site 10118 | Chattanooga | Tennessee | 37404 | — |
| Site 10142 | Beaumont | Texas | 77701 | — |
| Site 10120 | Fort Worth | Texas | 76104 | — |
| Site 10141 | Houston | Texas | 77022 | — |
| Site 10108 | Norfolk | Virginia | 23502 | — |
| Site 10154 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05617820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05617820 live on ClinicalTrials.gov.